These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies. Mitchel JF; Fram DB; Palme DF; Foster R; Hirst JA; Azrin MA; Bow LM; Eldin AM; Waters DD; McKay RG Circulation; 1995 Feb; 91(3):785-93. PubMed ID: 7828307 [TBL] [Abstract][Full Text] [Related]
4. Catheter-based local thrombolysis with urokinase: comparative efficacy of intraluminal clot lysis with conventional urokinase infusion techniques in an in vivo porcine thrombus model. Mitchel JF; Shwedick M; Alberghini TA; Knibbs D; McKay RG Cathet Cardiovasc Diagn; 1997 Jul; 41(3):293-302. PubMed ID: 9213028 [TBL] [Abstract][Full Text] [Related]
5. Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons. Azrin MA; Mitchel JF; Fram DB; Pedersen CA; Cartun RW; Barry JJ; Bow LM; Waters DD; McKay RG Circulation; 1994 Jul; 90(1):433-41. PubMed ID: 8026030 [TBL] [Abstract][Full Text] [Related]
6. Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: the Dispatch catheter. McKay RG; Fram DB; Hirst JA; Kiernan FJ; Primiano CA; Rinaldi MJ; Azrin MA; Mitchel JF; Waters DD Cathet Cardiovasc Diagn; 1994 Oct; 33(2):181-8. PubMed ID: 7834736 [TBL] [Abstract][Full Text] [Related]
7. Local urokinase delivery with the Channel balloon: device safety, pharmacokinetics of intracoronary drug delivery, and efficacy of thrombolysis. Mitchel JF; Barry JJ; Bow L; Alberghini TA; Abbas SA; McKay RG Cathet Cardiovasc Diagn; 1997 Jul; 41(3):254-60. PubMed ID: 9213023 [TBL] [Abstract][Full Text] [Related]
8. Treatment of acute stent thrombosis with local urokinase therapy using catheter-based, drug delivery systems: a case report. Mitchel JF; McKay RG Cathet Cardiovasc Diagn; 1995 Feb; 34(2):149-54. PubMed ID: 7788694 [TBL] [Abstract][Full Text] [Related]
9. Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. Nunes GL; Hanson SR; King SB; Sahatjian RA; Scott NA J Am Coll Cardiol; 1994 Jun; 23(7):1578-83. PubMed ID: 8195517 [TBL] [Abstract][Full Text] [Related]
10. Local delivery of nadroparin via hydrogel-coated angioplasty balloon: effect on platelet deposition and smooth muscle cell proliferation--an experimental study. Johnson MS; Bergmann CA; Carmody TJ; Dreesen RG; Barry JJ; Barina C; Orazi A; Ambrosius WT J Vasc Interv Radiol; 2000 Jan; 11(1):115-22. PubMed ID: 10693723 [TBL] [Abstract][Full Text] [Related]
11. Localized delivery of heparin to angioplasty sites with iontophoresis. Mitchel JF; Azrin MA; Fram DB; Bow LM; McKay RG Cathet Cardiovasc Diagn; 1997 Jul; 41(3):315-23. PubMed ID: 9213031 [TBL] [Abstract][Full Text] [Related]
12. Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion. Fram DB; Aretz T; Azrin MA; Mitchel JF; Samady H; Gillam LD; Sahatjian R; Waters D; McKay RG J Am Coll Cardiol; 1994 Jun; 23(7):1570-7. PubMed ID: 8195516 [TBL] [Abstract][Full Text] [Related]
13. Mural delivery of iloprost with use of hydrogel-coated balloon catheters suppresses local platelet aggregation. Kandarpa K; Nakatsuka S; Bravo SM; Harapanhalli RS; Barry JJ J Vasc Interv Radiol; 1997; 8(6):997-1004. PubMed ID: 9399469 [TBL] [Abstract][Full Text] [Related]
14. Intracoronary urokinase as an adjunct to percutaneous transluminal coronary angioplasty in patients with complex coronary narrowings or angioplasty-induced complications. Goudreau E; DiSciascio G; Vetrovec GW; Chami Y; Kohli R; Warner M; Sabri N; Cowley MJ Am J Cardiol; 1992 Jan; 69(1):57-62. PubMed ID: 1729868 [TBL] [Abstract][Full Text] [Related]
15. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Meyer BJ; Fernández-Ortiz A; Mailhac A; Falk E; Badimon L; Michael AD; Chesebro JH; Fuster V; Badimon JJ Circulation; 1994 Nov; 90(5):2474-80. PubMed ID: 7955205 [TBL] [Abstract][Full Text] [Related]
16. Local delivery of an antiproliferative drug with use of hydrogel-coated angioplasty balloons. Consigny PM; Barry JJ; Vitali NJ J Vasc Interv Radiol; 1994; 5(4):553-60. PubMed ID: 7949710 [TBL] [Abstract][Full Text] [Related]
17. Site-specific, catheter-based thrombolysis: a new technique for treating intracoronary thrombus and thrombus-containing stenosis. McKay RG J Invasive Cardiol; 1995; 7 Suppl E():36E-43E. PubMed ID: 10158388 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of urokinase during elective coronary angioplasty. Pavlides GS; Schreiber TL; Gangadharan V; Puchrowicz S; O'Neill WW Am Heart J; 1991 Mar; 121(3 Pt 1):731-7. PubMed ID: 2000738 [TBL] [Abstract][Full Text] [Related]
19. Rapid thrombus dissolution by continuous infusion of urokinase through an intracoronary perfusion wire prior to and following PTCA: results in native coronaries and patent saphenous vein grafts. Chapekis AT; George BS; Candela RJ Cathet Cardiovasc Diagn; 1991 Jun; 23(2):89-92. PubMed ID: 2070409 [TBL] [Abstract][Full Text] [Related]
20. Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model. Fram DB; Mitchel JF; Azrin MA; Chow MS; Waters DD; McKay RG Cathet Cardiovasc Diagn; 1997 Jul; 41(3):275-86. PubMed ID: 9213026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]